# Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG)

> **NCT01248728** · PHASE2 · COMPLETED · sponsor: **Holland Bloorview Kids Rehabilitation Hospital** · enrollment: 38 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 Fatty Acids
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01248728
- **Lead sponsor:** Holland Bloorview Kids Rehabilitation Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01248728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01248728, "Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01248728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*